A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood.
Phase 3
Completed
- Conditions
- Candidiasis
- Registration Number
- NCT00163111
- Lead Sponsor
- Pfizer
- Brief Summary
This is a study to investigate the safety and efficacy of voriconazole for the treatment of candidemia in critically ill non-neutropenic patients
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 412
Inclusion Criteria
- Patients with candidemia
Exclusion Criteria
- Neutropenia
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Sustained clinical response for 12 weeks from end of treatment
- Secondary Outcome Measures
Name Time Method Time to negative blood cultures